>>https://rayviolet.blogspot.com/2022/03/big-pharma-investing-billion...
One marijuana FDA-approved pharmaceutical product is currently being used to treat children for epilepsy, and the FDA is expected to approve another marijuana-based drug soon for treating multiple sclerosis.
According to Fierce Pharma, the company with the first FDA-approved marijuana drug is investing $100 million to grow more pot, although if you try to grow some for yourself, depending on which state you live in, you could be arrested, spend time in prison, and have your children removed from your custody.
Jazz Pharmaceuticals, after getting its hands on the industry’s first FDA-approved cannabis-based medicine last February, is angling to keep its crown with a major manufacturing push overseas.
Jazz and its star cannabinoid subsidiary GW have kicked off construction of a new U.K. manufacturing plant at Kent Science Park in Sittingbourne, the companies said Friday.
Jazz will invest more than $100 million into the 60,000-square-foot facility, where it plans to hire 100-plus staffers once the site is operational. The plant is expected to open in 2024, and it will specifically support manufacture of Jazz and GW’s two approved cannabis-based medicines.
Those are the seizure med Epidiolex, which boasts a green light in the U.S., and late-stage multiple sclerosis candidate nabiximols, which is known as Sativex outside the States. The Kent Science Park site will also help bolster future capacity for new meds in the company’s pipeline, Jazz said. ...>>>https://rayviolet.blogspot.com/2022/03/big-pharma-investing-billion...
You need to be a member of Saviors Of Earth to add comments!
Join Saviors Of Earth